Leukotrienes New Concepts and Targets for Therapy
In the two decades since the elusive "slow reacting substance of anaphylaxis" (SRS-A) was identified as a product of the action of the 5-lipoxygenase enzyme on arachidonic acid, it has been well established that the leukotrienes are key mediators of both alIergy and inflammation. Their rel...
| Other Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Dordrecht
Springer Netherlands
1998, 1998
|
| Edition: | 1st ed. 1998 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- 1 Molecular mechanisms of leukotriene synthesis: the changing paradigm
- 2 Leukotriene receptors
- 3 Enzymes involved in the production of leukotrienes and related molecules
- 4 Cysteinyl-leukotriene receptors and transduction mechanisms in airway cells
- 5 How to measure leukotrienes in man
- 6 Influence of leukotrienes and anti-leukotrienes on airway tone and migration of inflammatory cells
- 7 Leukotrienes in airways obstruction and inflammation evoked by allergen
- 8 Leukotrienes in induced airway obstruction
- 9 Role of leukotrienes in aspirin-induced asthma
- 10 How to use anti-leukotrienes in the treatment of asthma
- 11 Transcription factors HSF and HF-?B as targets for cytoprotective eicosanoids: a new strategy for therapeutic intervention
- 12 Vascular biology of the leukotrienes
- 13 Leukotrienes in cardiovascular disease
- 14 Leukotriene B4: agonist for the fat regulator PPAR?
- 15 The role of leukotrienes in rhinitis